Trademark: 90828261
Status Date
Wednesday, January 10, 2024
Filing Date
Wednesday, July 14, 2021
Published for Opposition
Tuesday, November 15, 2022
40 Custom manufacture of pharmaceuticals for others; Custom manufacturing of biological cells; consultation in the field of custom manufacture of pharmaceuticals and biological cells
5 Gene therapy products, namely, engineered cell platforms for immunotherapy purposes; Pharmaceutical preparations for use in the treatment of autoimmune diseases and disorders, autoinflammatory diseases and disorders, alloimmune diseases and disorders and allergic diseases and disorders
42 Scientific research; Pharmaceutical research; Medical research; Engineering of biological cells; genetic engineering of biological cells; Technological consultation services in the fields of engineering of biological cells; Laboratory research services in the field of immunology and cellular engineering
Jan 12, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 10, 2024
Sou Extension 2 Granted
Jan 10, 2024
Sou Extension 2 Filed
Jan 10, 2024
Sou Teas Extension Received
Jul 12, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 10, 2023
Sou Extension 1 Granted
Jul 10, 2023
Sou Extension 1 Filed
Jul 10, 2023
Sou Teas Extension Received
Jan 10, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 15, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 15, 2022
Published For Opposition
Oct 26, 2022
Notification Of Notice Of Publication E-Mailed
Oct 7, 2022
Approved For Pub - Principal Register
Oct 5, 2022
Teas/Email Correspondence Entered
Oct 5, 2022
Correspondence Received In Law Office
Oct 5, 2022
Teas Response To Office Action Received
Apr 7, 2022
Notification Of Non-Final Action E-Mailed
Apr 7, 2022
Non-Final Action E-Mailed
Apr 7, 2022
Non-Final Action Written
Apr 3, 2022
Assigned To Examiner
Sep 17, 2021
New Application Office Supplied Data Entered
Jul 17, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
